Olachi Anuforom
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Olachi Anuforom has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
Graham R. Wallace
University of Birmingham
1 shared publication- Laura Jane Violet Piddock
Global Antibiotic Research and Development Partnership (GARDP), Geneva, Switzerland
1 shared publication
Latest Publications
- 5 September 2014
- Published by Springer Nature in Medical Microbiology and Immunology
- Vol. 204 (2) , 151-159
The immune response and antibacterial therapy
The host’s immune defence mechanisms are indispensable factors in surviving bacterial infections. However, in many circumstances, the immune system alone is inadequate. Since the 1940s, the use of antibacterial therapy has saved millions of lives, improving the span and quality of life of individuals. Unfortunately, we are now facing an era where antibacterial agents are threatened by resistance. In addition to targeting bacteria, some antibacterial agents affect various aspects of the immune response to infection. Since many antibacterial drugs are failing in efficacy due to resistance, it has been strongly suggested that any synergy between these drugs and the immune response be exploited in the treatment of bacterial infections. This review explores the influence of antibacterial therapy on the immune response and new approaches that could exploit this interaction for the treatment of bacterial infections.
- 5 September 2014
- Published by Springer Nature in Medical Microbiology and Immunology
- Vol. 204 (2) , 151-159
The immune response and antibacterial therapy
The host’s immune defence mechanisms are indispensable factors in surviving bacterial infections. However, in many circumstances, the immune system alone is inadequate. Since the 1940s, the use of antibacterial therapy has saved millions of lives, improving the span and quality of life of individuals. Unfortunately, we are now facing an era where antibacterial agents are threatened by resistance. In addition to targeting bacteria, some antibacterial agents affect various aspects of the immune response to infection. Since many antibacterial drugs are failing in efficacy due to resistance, it has been strongly suggested that any synergy between these drugs and the immune response be exploited in the treatment of bacterial infections. This review explores the influence of antibacterial therapy on the immune response and new approaches that could exploit this interaction for the treatment of bacterial infections.